INCIDENCE AND FEATURES OF LIVER-DISEASE IN PATIENTS ON CHRONIC-HEMODIALYSIS

被引:23
作者
BRUGUERA, M [1 ]
VIDAL, L [1 ]
SANCHEZTAPIAS, JM [1 ]
COSTA, J [1 ]
REVERT, L [1 ]
RODES, J [1 ]
机构
[1] UNIV BARCELONA, HOSP CLIN & PROV, NEPHROL SERV, E-08036 BARCELONA, SPAIN
关键词
Chronic renal failure; Hemodialysis; Hepatitis; Hepatitis B; Hepatitis non-A; non-B; Liver disease;
D O I
10.1097/00004836-199006000-00013
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
We examined the incidence and features of liver disease and the presence of serologic markers of hepatitis B virus (HBV) infection in 134 patients on hemodialysis for 2 to 14 years. Twenty-three patients (17%) had had a single episode of acute hepatitis while on dialysis and two patients had had two episodes, which were attributed to infection by hepatitis B virus in 7 instances and by hepatitis non-A, non-B virus in 20. Chronicity supervened in 4 cases of hepatitis B (57%) and in 14 cases of hepatitis non-A, non-B (70%). A prolonged rise of serum aminotransferases, which was not preceded by acute hepatitis, was detected in 23 additional patients (17%). Acute hepatitis and prolonged hypertransaminasemia were more frequent in patients dialyzed at a hospital unit than in patients dialyzed outside the hospital or at home. These observations indicate that development of acute and chronic liver disease, mainly hepatitis non-A, non-B, is frequent in patients on chronic hemodialysis, particularly in those dialyzed in hospital. Serologic evidence of current or past infection by HBV was detected in 57 patients (42%) with sustained positivity of HBV serum markers. Transient positivity for anti-HBc, anti-HBs, or both, possibly related to passive transmission of antibodies by blood transfusion, was observed in 20 patients (15%). These findings indicate that periodic, repeated testing for HBV serum markers is necessary only in a minority of patients on long-term hemodialysis. © 1990 Raven Press, Ltd., New York.
引用
收藏
页码:298 / 302
页数:5
相关论文
共 26 条
[1]  
ACI M, 1980, JAMA-J AM MED ASSOC, V244, P343
[2]   POSTTRANSFUSION HEPATITIS AFTER EXCLUSION OF COMMERCIAL AND HEPATITIS-B ANTIGEN-POSITIVE DONORS [J].
ALTER, HJ ;
SCHMIDT, PJ ;
MORROW, AG ;
HOLLAND, PV ;
PURCELL, RH ;
LANDER, JJ ;
FEINSTONE, SM .
ANNALS OF INTERNAL MEDICINE, 1972, 77 (05) :691-+
[3]   IMPACT OF INFECTION CONTROL STRATEGIES ON THE INCIDENCE OF DIALYSIS-ASSOCIATED HEPATITIS IN THE UNITED-STATES [J].
ALTER, MJ ;
FAVERO, MS ;
MAYNARD, JE .
JOURNAL OF INFECTIOUS DISEASES, 1986, 153 (06) :1149-1151
[4]  
BARRERA JM, 1987, MED CLIN-BARCELONA, V89, P759
[5]   NONVIRAL HEPATITIS IN PATIENTS MAINTAINED BY LONG-TERM DIALYSIS [J].
BERGMAN, LA ;
DUNEA, G ;
SMITH, EC ;
THOMAS, W ;
REDDY, CR ;
ELLISON, MR .
ARCHIVES OF INTERNAL MEDICINE, 1972, 130 (01) :96-&
[6]  
BRUGUERA M, 1987, POSTGRAD MED J, V63, P155
[7]  
CROSNIER J, 1981, LANCET, V1, P797
[8]  
DIAZ AL, 1984, MED CLIN-BARCELONA, V82, P538
[9]  
FENNELL RS, 1981, PEDIATRICS, V67, P855
[10]   HEPATITIS-B VIRUS MARKERS IN 97 LONG-TERM HEMODIALYSIS-PATIENTS [J].
GAHL, GM ;
HESS, G ;
ARNOLD, W ;
GRAMS, G .
NEPHRON, 1979, 24 (02) :58-63